Dietary levels of trans-fatty acids:: basis for health concerns and industry efforts to limit use

被引:64
作者
Hunter, JE [1 ]
机构
[1] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA
关键词
trans-fatty acids; LDL cholesterol; HDL cholesterol; trans-fat alternatives; hydrogenation; interesterification; oil fractions; trait-enhanced oils;
D O I
10.1016/j.nutres.2005.04.002
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Dietary trans-fatty acids at sufficiently high levels have been found to increase low-density lipoprotein cholesterol and decrease high-density lipoprotein cholesterol compared with diets high in cis monounsaturated or polyunsaturated fatty acids. The dietary levels of trans-fatty acids necessary to do this appear to be approximately 4% of energy or higher to increase low-density lipoprotein cholesterol and approximately 5% to 6% of energy or higher to decrease high-density lipoprotein cholesterol, compared with control diets essentially trans-free. In response, the food industry is working on ways to eliminate or greatly reduce trans-fatty acids in food products. Current efforts focus on 4 technological options: (1) modification of the hydrogenation process, (2) use of interesterification, (3) use of fractions high in solids from natural oils, and (4) use of trait-enhanced oils. Challenges to the food industry in replacing trans-fatty acids in foods are to develop formulation options that provide equivalent functionality, are economically feasible, do not greatly increase saturated fatty acid content, and meet the regulatory deadline of January 1, 2006. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:499 / 513
页数:15
相关论文
共 30 条
[1]  
AHUJA JKC, 1997, INDIVIDUAL FATTY ACI
[2]   Estimated intakes of trans fatty and other fatty acids in the US population [J].
Allison, DB ;
Egan, SK ;
Barraj, LM ;
Caughman, C ;
Infante, M ;
Heimbach, JT .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1999, 99 (02) :166-174
[3]   Stearic acid, trans fatty acids, and dairy fat: Effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects [J].
Aro, A ;
Jauhiainen, M ;
Partanen, R ;
Salminen, I ;
Mutanen, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (05) :1419-1426
[4]   Trans fatty acids and coronary heart disease [J].
Ascherio, A ;
Katan, MB ;
Zock, PL ;
Stampfer, MJ ;
Willett, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1994-1998
[5]  
Feldman EB, 1996, AM J CLIN NUTR, V63, P663
[6]  
GRUNDY SM, 1990, J LIPID RES, V31, P1149
[7]   Trends in the trans-fatty acid composition of the diet in a metropolitan area:: The Minnesota Heart Survey [J].
Harnack, L ;
Lee, S ;
Schakel, SF ;
Duval, S ;
Luepker, RV ;
Arnett, DK .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2003, 103 (09) :1160-1166
[8]  
*HLTH COUNC NETH, 2001, PUBL HLTH COUNC NETH, P104
[9]   Intake of fatty acids in western Europe with emphasis on trans fatty acids:: The TRANSFAIR study [J].
Hulshof, KFAM ;
van Erp-Baart, MA ;
Anttolainen, M ;
Becker, W ;
Church, SM ;
Couet, C ;
Hermann-Kunz, E ;
Kesteloot, H ;
Leth, T ;
Martins, I ;
Moreiras, O ;
Moschandreas, J ;
Pizzoferrato, L ;
Rimestad, AH ;
Thorgeirsdottir, H ;
van Amelsvoort, JMM ;
Aro, A ;
Kafatos, AG ;
Lanzmann-Petithory, D ;
van Poppel, G .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1999, 53 (02) :143-157
[10]   Studies on effects of dietary fatty acids as related to their position on triglycerides [J].
Hunter, JE .
LIPIDS, 2001, 36 (07) :655-668